by administrator | Jul 5, 2017 | Encyt Technologies, News
See original story here Encyt Technologies, Inc., a leading biotech cancer research organization based in Nova Scotia, Canada, recently filed a series of patents for novel treatments to reverse resistance to immunotherapy using checkpoint inhibitors. According to...
